EyeKor provides imaging management and analysis services for ophthalmic clinical and preclinical studies, through an innovative technology platform that allows unprecedented ability to track study progress and share image data among study stakeholders.
From clinical site certification through grading data export, EyeKor can manage each step of clinical trial imaging through the unique EXCELSIOR™ platform. With EXCELSIOR™, data and images can easily be shared between clinical sites, reading centers, CROs and sponsors for maximum transparency. EXCELSIOR™ provides ease of access and workflow control to make managing global ophthalmic trials involving multiple reading centers and analysis of multiple modalities not only feasible but practical.
Implementing quantitive and objective diagnostic biomarkers is a critical element in clinical trial protocol design and execution. EyeKor and its partners have extensive expertise to assist you choosing the right biomarkers that reflect accurately the characteristics of disease progression and treatment effects.
A successful journey requires all equipment working in concert; the same applies to conducting a clinical trial. A successful multi-center trial requires intrinsic understanding of various imaging techniques, developing meaningful outcome correlations, and formulating computational methodologies that yield high sensitivity and specificity.
The EyeKor team provides the consultation, documentation and training to make sure your trial starts off on the right foot. Using EXCELSIOR™, EyeKor's cloud-based, FDA 510(K) cleared data management system, EyeKor will support you and your team from start-up through every phase of your clinical trial journey.
EXCELSIOR™ is a first-of-its kind application featuring cloud-based architecture designed to enhance efficiency and accuracy in the collection and interpretation of ophthalmic clinical trial data.
The long and winding road toward an ophthalmic trial begins well before the clinic. Through its partnership with Ocular Services On Demand (OSOD) and the EXCELSIOR™ preclinical platform, EyeKor can establish your path toward success from laboratory to clinical trials, and beyond.